In terms of research on blood apelin-13 levels, both Ali et al. [9] and Cekmez et al. [2] observed significantly lower blood apelin-13 levels in the ROP group than in the control group, which is consistent with the results of our study. The gene discussed is APLN; the disease is retinopathy of prematurity.